Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/01/2014US20140121171 Treatment for muscular dystrophies
05/01/2014US20140121166 Compositions and methods for the treatment of juvenile neuronal ceroid lipofuscinosis and related disorders
05/01/2014US20140121165 Induction of the Mitochondrial Permeability Transition
05/01/2014US20140121156 Nutritional approach to the control of anemia, diabetes and other diseases or conditions and prevention of associated comorbid states with the use of ergothioneine
05/01/2014US20140121155 Crystal Forms of Saxagliptin and Processes for Preparing Same
05/01/2014US20140120191 Method of treating a disorder associated with sequestered bacteria
05/01/2014US20140120187 Composition for accelerating change in muscle type
05/01/2014US20140120185 Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorder
05/01/2014US20140120182 Method for the treatment of cancer
05/01/2014US20140120181 Composition comprising phosphatidylcholine as an active ingredient for attenuating toxicity of anticancer agent
05/01/2014US20140120175 Visual Performance and/or Macular Pigmentation
05/01/2014US20140120172 Alcoholic injury mitigating agent
05/01/2014US20140120171 Therapeutic application of parenteral krill oil
05/01/2014US20140120169 Device and method for encapsulation of hydrophilic materials
05/01/2014US20140120166 Composition of entacopone
05/01/2014US20140120165 Corticosteroid particles and method of production
05/01/2014US20140120164 Polymer release system
05/01/2014US20140120163 Coated tablet formulation and method
05/01/2014US20140120160 Composition for cosmetic, pharmaceutical and dietary applications
05/01/2014US20140120150 Dissolvable Strip for Treatment of Oral Thermal Burns
05/01/2014US20140120121 Medicinal treatment of atopic inflammatory diseases
05/01/2014US20140120116 Treatment of cancer using smad3 inhibitor
05/01/2014US20140120112 Therapeutics for age-related macular degeneration
05/01/2014US20140120111 Treatment of autoimmune disorders and infections using antagonists of sgk1 activity
05/01/2014US20140120104 Cadherin-11 ec1 domain antagonists for treating inflammatory joint disorders
05/01/2014US20140120088 Agents for the treatment of tumors
05/01/2014US20140120087 Triazolopyridines
05/01/2014US20140120084 Methods of administering beta7 integrin antagonists
05/01/2014US20140120083 Treatment of cancers using pi3 kinase isoform modulators
05/01/2014US20140120079 Compositions and Methods for Diagnosing and Treating Diabetic Micro Vascular Complications
05/01/2014US20140120069 Amphoteric Materials Based on Crosslinked Hyaluronic Acid, Method of Preparation Thereof, Materials Containing Entrapped Active Agents, Method of Preparation Thereof, and Use of Said Materials
05/01/2014US20140120061 Abuse resistant melt extruded formulation having reduced alcohol interaction
05/01/2014US20140120060 Treatment of rheumatoid arthritis and asthma using pi3 kinase inhibitors
05/01/2014US20140120057 Polymers and methods thereof for wound healing
05/01/2014US20140120052 Composition and method for arresting blood flow and for forming a persistent microbial barrier
05/01/2014US20140120038 Nanoparticles for imaging and treating chlamydial infection
05/01/2014US20140116916 Therapy for Constipation
05/01/2014US20140116435 Inhaler for the administration of an anticholinergic
05/01/2014US20140116434 Dry Powder Inhaler Compositions
05/01/2014US20140116118 Ipa as a therapeutic agent, as a protective agent, and as a biomarker of disease risk
05/01/2014CA2805093A1 Anti-tumor agent otx-008 targets human galectin-1
04/2014
04/30/2014EP2725107A1 DNA sequencing with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators
04/30/2014EP2725103A2 Methods and compositions for treating prostate cancer
04/30/2014EP2725101A1 Protein comprising truncated form of extracellular domain protein of frizzled 2, and pharmaceutical composition for treating bone diseases which comprises said protein
04/30/2014EP2725031A1 C-glycoside derivatives
04/30/2014EP2725029A1 New antibacterial compounds and biological applications thereof
04/30/2014EP2725028A1 Substituted pyrazolo[1,5-]pyrimidine compounds as intermediates in the synthesis of TRK kinase inhibitors
04/30/2014EP2725025A1 Derivatives of 1H-indole-3-carboxamide and their use as P2Y12 antagonists
04/30/2014EP2725024A1 Azole heterocyclic compound, preparation method, pharmaceutical composition and use
04/30/2014EP2725018A1 Substituted cinnamamide derivative, preparation method and use thereof
04/30/2014EP2725016A1 Heterocyclic carboxylic acid ester derivative
04/30/2014EP2725015A1 Uracil or thymine derivative for treating hepatitis c
04/30/2014EP2725013A1 Novel histone deacetylase inhibitor of benzamides and use thereof
04/30/2014EP2725010A1 Amide compound, preparation method and uses thereof
04/30/2014EP2725008A1 N,N-dihalogenated amino acids and derivatives
04/30/2014EP2725004A1 Reduced coenzyme q10 crystal having excellent stability
04/30/2014EP2724733A1 Hydrophobic polymer compound having anticoagulant effect
04/30/2014EP2724729A1 Apoptosis-inducing agent
04/30/2014EP2724723A1 Tegaserod for use in the treatment of nerve injuries
04/30/2014EP2724722A1 Method of restoring the incretin effect
04/30/2014EP2724721A1 Composition for use in the treatment of Angelman syndrome and/or autism spectrum disorder, the use of such composition and a method for manufacturing a medicament for the treatment of Angelman syndrome and/or autism spectrum disorder
04/30/2014EP2724720A1 Compositions of phenylephrine useful for treatment of respiratory illness
04/30/2014EP2724719A1 Temporary embolization using inverse thermosensitive polymers
04/30/2014EP2724707A2 Hair care products with anti-dandruff ingredients and a cationic keratin hydrolysate
04/30/2014EP2724704A1 Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol
04/30/2014EP2724156A1 Methods and compositions for treatment of cancer and autoimmune disease
04/30/2014EP2723881A2 Novel crystalline cefoperazone intermediate
04/30/2014EP2723866A1 Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
04/30/2014EP2723864A2 Phenocopy model of disease
04/30/2014EP2723863A1 Hcv combination therapy
04/30/2014EP2723774A1 Method for manufacturing hydroxyethyl starch derivatives
04/30/2014EP2723756A2 Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genes
04/30/2014EP2723755A1 New family of analogues and nadp+ or nadph, their preparation and their application in therapeutics
04/30/2014EP2723754A1 Multivalent [beta]- 1 - 2 - linked mannose oligosaccharides as immunostimulatory compounds and uses thereof
04/30/2014EP2723753A1 Selective glycosidase inhibitors and uses thereof
04/30/2014EP2723751A1 Proteasome inhibitors and processes for their preparation, purification and use
04/30/2014EP2723748A1 Heterocyclyl aminoimidazopyridazines
04/30/2014EP2723747A1 Compounds useful as inhibitors of atr kinase
04/30/2014EP2723746A1 Compounds useful as inhibitors of atr kinase
04/30/2014EP2723745A1 Compounds useful as inhibitors of atr kinase
04/30/2014EP2723744A1 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES
04/30/2014EP2723743A1 10h-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof
04/30/2014EP2723742A1 10h-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof
04/30/2014EP2723741A2 Substituted imidazopyridinyl-aminopyridine compounds
04/30/2014EP2723740A1 Solid forms and salts of tetrahydro-pyrido-pyrimidine derivatives
04/30/2014EP2723739A1 Substituted 6-aza-isoindolin-1-one derivatives
04/30/2014EP2723738A1 Crystal of fused heterocyclic compound
04/30/2014EP2723737A1 Bridged bicyclic compounds for the treatment of bacterial infections
04/30/2014EP2723736A1 7-azaindole derivatives suitable for treatment of cancers
04/30/2014EP2723733A1 Polymorphs of (s)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl}-amide
04/30/2014EP2723732A1 Trpv1 antagonists including dihydroxy substituent and uses thereof
04/30/2014EP2723731A1 Metalloenzyme inhibitor compounds
04/30/2014EP2723729A1 Pesticidal compositions and processes related thereto
04/30/2014EP2723728A1 Process for the preparation of dexlansoprazole
04/30/2014EP2723724A1 Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
04/30/2014EP2723722A1 3,5-diamino-6-chloro-n-(n-(4-(4-(2-(hexyl (2,3,4,5,6-pentahydroxyhexyl) amino) ethoxy) phenyl) butyl) carbamimidoyl) pyrazine-2-carboxamide
04/30/2014EP2723719A1 Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
04/30/2014EP2723718A1 Trpm8 antagonists and their use in treatments
04/30/2014EP2723717A2 Trpm8 antagonists and their use in treatments
04/30/2014EP2723716A1 Amido-pyridyl ether compounds and compositions and their use against parasites
1 ... 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 ... 7860